Mariah L. Johnson

Mariah L. Johnson's work focuses on acute myeloid leukemia (AML), a blood cancer, with particular attention to finding new drug targets and treatment combinations, including therapies that alter cell metabolism (such as pyrimidine depletion and DHODH inhibitors), epigenetic regulation (EZH2 inhibition), and immune-based approaches. This research often uses mouse models of AML to test how new drugs perform alone or combined with existing therapies.

Publication output has been low and irregular over the past decade, with small numbers of papers most years and no publications in several years (2021, 2023), averaging less than one per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026